See more : MYUNGMOON Pharm co.,Ltd (017180.KS) Income Statement Analysis – Financial Results
Complete financial analysis of Westlake Chemical Partners LP (WLKP) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Westlake Chemical Partners LP, a leading company in the Chemicals industry within the Basic Materials sector.
You may be interested
- District Metals Corp. (DMX.V) Income Statement Analysis – Financial Results
- Star8 Corporation (STRH) Income Statement Analysis – Financial Results
- Tatva Chintan Pharma Chem Limited (TATVA.NS) Income Statement Analysis – Financial Results
- Watermark Lodging Trust, Inc. (WRMK) Income Statement Analysis – Financial Results
- Spiffbet AB (SPIFF.ST) Income Statement Analysis – Financial Results
Westlake Chemical Partners LP (WLKP)
About Westlake Chemical Partners LP
Westlake Chemical Partners LP acquires, develops, and operates ethylene production facilities and related assets in the United States. The company's ethylene production facilities primarily convert ethane into ethylene. It also sells ethylene co-products, including propylene, crude butadiene, pyrolysis gasoline, and hydrogen directly to third parties on either a spot or contract basis. Westlake Chemical Partners GP LLC serves as the general partner of the company. The company was incorporated in 2014 and is headquartered in Houston, Texas.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.19B | 1.59B | 1.21B | 966.67M | 1.09B | 1.29B | 1.17B | 986.74M | 1.01B | 1.75B | 2.13B | 2.25B | 2.25B |
| Cost of Revenue | 803.33M | 1.22B | 773.15M | 587.79M | 712.44M | 908.46M | 769.31M | 595.41M | 624.34M | 1.00B | 1.26B | 1.61B | 1.84B |
| Gross Profit | 387.46M | 377.37M | 441.71M | 378.88M | 379.43M | 377.16M | 403.67M | 391.33M | 382.88M | 745.81M | 872.61M | 635.65M | 409.10M |
| Gross Profit Ratio | 32.54% | 23.69% | 36.36% | 39.19% | 34.75% | 29.34% | 34.41% | 39.66% | 38.01% | 42.63% | 41.01% | 28.26% | 18.17% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 27.09M | 26.62M | 28.58M | 22.16M | 26.95M | 24.62M | 27.26M | 21.97M | 20.68M | 21.30M | 24.05M | 22.49M | 0.00 |
| Selling & Marketing | 2.67M | 3.06M | 2.44M | 3.73M | 2.33M | 2.97M | 2.00M | 2.92M | 2.87M | 7.95M | 1.40M | 1.62M | 0.00 |
| SG&A | 29.75M | 29.68M | 31.02M | 25.90M | 29.28M | 27.59M | 29.26M | 24.89M | 23.55M | 29.26M | 25.45M | 24.10M | 24.31M |
| Other Expenses | 0.00 | 1.57M | 62.00K | 733.00K | 3.10M | 2.46M | 1.79M | 601.00K | 160.00K | 3.15M | 7.70M | 4.19M | 2.80M |
| Operating Expenses | 29.75M | 29.68M | 31.02M | 25.90M | 29.28M | 27.59M | 29.26M | 24.89M | 23.55M | 29.26M | 25.45M | 24.10M | 24.31M |
| Cost & Expenses | 833.08M | 1.25B | 804.17M | 613.68M | 741.72M | 936.05M | 798.57M | 620.29M | 647.89M | 1.03B | 1.28B | 1.64B | 1.87B |
| Interest Income | 0.00 | 13.41M | 8.82M | 12.04M | 19.62M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 26.50M | 13.41M | 8.82M | 12.04M | 19.62M | 21.43M | 21.86M | 12.61M | 4.97M | 10.50M | 8.03M | 8.94M | 8.95M |
| Depreciation & Amortization | 110.20M | 121.07M | 108.81M | 103.15M | 107.32M | 108.84M | 113.99M | 98.21M | 81.21M | 77.61M | 73.46M | 64.26M | 57.19M |
| EBITDA | 472.14M | 470.33M | 519.56M | 456.88M | 460.57M | 460.87M | 490.18M | 464.92M | 440.51M | 797.32M | 928.32M | 679.99M | 444.78M |
| EBITDA Ratio | 39.65% | 29.52% | 42.77% | 47.26% | 42.18% | 35.85% | 41.79% | 47.15% | 43.75% | 45.57% | 43.63% | 30.23% | 19.76% |
| Operating Income | 357.71M | 347.69M | 410.69M | 352.99M | 350.15M | 349.57M | 374.41M | 366.44M | 359.33M | 716.56M | 847.16M | 611.55M | 384.79M |
| Operating Income Ratio | 30.04% | 21.82% | 33.81% | 36.52% | 32.07% | 27.19% | 31.92% | 37.14% | 35.68% | 40.95% | 39.81% | 27.19% | 17.09% |
| Total Other Income/Expenses | -22.27M | -11.84M | -8.75M | -11.31M | -16.53M | -18.98M | -20.07M | -12.01M | -4.81M | -7.35M | -331.00K | -4.75M | -6.14M |
| Income Before Tax | 335.44M | 335.85M | 401.93M | 341.68M | 333.62M | 330.59M | 354.34M | 354.44M | 354.53M | 709.21M | 846.83M | 606.80M | 378.64M |
| Income Before Tax Ratio | 28.17% | 21.08% | 33.08% | 35.35% | 30.56% | 25.71% | 30.21% | 35.92% | 35.20% | 40.53% | 39.80% | 26.98% | 16.82% |
| Income Tax Expense | 813.00K | 1.02M | 549.00K | 564.00K | 728.00K | 22.00K | 1.28M | 1.04M | 672.00K | 199.39M | 300.28M | 210.88M | 131.67M |
| Net Income | 54.28M | 334.83M | 401.39M | 341.12M | 332.90M | 49.35M | 48.67M | 40.94M | 39.83M | 13.58M | 546.55M | 395.92M | 246.97M |
| Net Income Ratio | 4.56% | 21.02% | 33.04% | 35.29% | 30.49% | 3.84% | 4.15% | 4.15% | 3.95% | 0.78% | 25.69% | 17.60% | 10.97% |
| EPS | 1.54 | 9.51 | 11.40 | 9.69 | 9.65 | 1.53 | 1.72 | 1.50 | 1.47 | 0.50 | 21.54 | 15.60 | 9.73 |
| EPS Diluted | 1.54 | 9.51 | 11.40 | 9.69 | 9.65 | 1.51 | 1.72 | 1.50 | 1.47 | 0.50 | 21.54 | 15.60 | 9.73 |
| Weighted Avg Shares Out | 35.22M | 35.22M | 35.21M | 35.20M | 34.49M | 32.24M | 28.39M | 27.06M | 27.06M | 27.06M | 25.37M | 25.37M | 25.37M |
| Weighted Avg Shares Out (Dil) | 35.22M | 35.22M | 35.21M | 35.20M | 34.49M | 32.68M | 28.39M | 27.29M | 27.10M | 27.06M | 25.37M | 25.37M | 25.37M |
Westlake Chemical Partners LP Announces Third Quarter 2022 Distribution
HOUSTON--(BUSINESS WIRE)--The Board of Directors of Westlake Chemical Partners GP LLC, the general partner of Westlake Chemical Partners LP (the "Partnership") (NYSE:WLKP), has declared a distribution of $0.4714 per unit.
Westlake Chemical Partners LP Announces Third Quarter 2022 Distribution
HOUSTON--(BUSINESS WIRE)--The Board of Directors of Westlake Chemical Partners GP LLC, the general partner of Westlake Chemical Partners LP (the "Partnership") (NYSE:WLKP), has declared a distribution of $0.4714 per unit. This is the 33rd quarterly distribution announced by the Partnership...
Westlake Chemical Partners Announce Third Quarter 2022 Earnings Conference Call
HOUSTON--(BUSINESS WIRE)--Westlake Chemical Partners (NYSE: WLKP) will release its third quarter 2022 earnings prior to the market opening on Thursday, November 3, 2022. The company will host a conference call at 1:00 p.m. Eastern Time (12:00 p.m. Central Time) on...
Westlake Chemical Partners Provides Tax Reporting Information
HOUSTON--(BUSINESS WIRE)--Westlake Chemical Partners (NYSE: WLKP) today provided the following information regarding 2021 investor tax reporting: As previously noted in the 2021 Investor Tax Reporting Package for your investment in Westlake Chemical Partners, LP, the Partnership will report items of...
Westlake Chemical Partners Getting Crimped By Feedstock But Still Cheap
Westlake Chemical Partners is dealing with higher natural gas and naphtha prices which are hurting margins. While cash flows are pretty safe on the demand side thanks to sales agreements with affiliated Westlake, the elevated energy costs are a problem...
Westlake Chemical Partners LP (WLKP) CEO Albert Chao on Q2 2022 Results - Earnings Call Transcript
Westlake Chemical Partners LP (NYSE:WLKP ) Q2 2022 Earnings Conference Call August 2, 2022 1:00 PM ET Company Participants Jeff Holy - Vice President and Treasurer Albert Chao - President and Chief Executive Officer Steve Bender - Executive Vice President...
Westlake Chemical Partners LP Announces Second Quarter 2022 Results
HOUSTON--(BUSINESS WIRE)--Westlake Chemical Partners LP (NYSE: WLKP) (the "Partnership") today reported net income attributable to the Partnership in the second quarter of 2022 of $16.4 million, or $0.47 per limited partner unit, a decrease of $8.7 million compared to second...
Westlake Chemical Partners LP Announces Second Quarter 2022 Results
HOUSTON--(BUSINESS WIRE)--Westlake Chemical Partners LP (NYSE: WLKP) (the "Partnership") today reported net income attributable to the Partnership in the second quarter of 2022 of $16.4 million, or $0.47 per limited partner unit, a decrease of $8.7 million compared to second...
Westlake Chemical Partners LP Announces Second Quarter 2022 Results
HOUSTON--(BUSINESS WIRE)--Westlake Chemical Partners LP (NYSE: WLKP) (the "Partnership") today reported net income attributable to the Partnership in the second quarter of 2022 of $16.4 million, or $0.47 per limited partner unit, a decrease of $8.7 million compared to second...
Westlake Chemical Partners LP Announces Second Quarter 2022 Distribution
HOUSTON--(BUSINESS WIRE)--The Board of Directors of Westlake Chemical Partners GP LLC, the general partner of Westlake Chemical Partners LP (the "Partnership") (NYSE:WLKP), has declared a distribution of $0.4714 per unit. This is the 32nd quarterly distribution announced by the Partnership...
Source: https://incomestatements.info
Category: Stock Reports